Belle is the trademark of BelleTorus Corp., the US-based company that we cofounded. For now, Belle’s algorithm is the strongest one in dermatology. Through its precision and speed, the algorithm allows the physician to get the best results as fast as possible in relation to skin diseases. In the future, Belle will be able to diagnose individual skin diseases. On June 29th, Belle officialized its partnership with Medzino.
What is Medzino?
Medzino is a telehealthcare platform. Based in the US, this app links physicians with patients throughout 39 states. This platform includes many types of care such as mental health, chronic diseases, well being, etc. After a consultation and considering the risks, the physicians are able to prescribe medication for the patient. Medzino takes charge of the consultation, the diagnosis and the medication of the patient.
The partnership between Belle Ai and Medzino
The partnership between Medzino and Belle Ai offers a great opportunity for both services. Indeed, Belle’s algorithm is promoted on the platform in the skin healthcare section through the acne and eczema analysis. Medzino has also, through chosing a partnership with Belle, the strongest algorithm on its side.
This partnership is also a great opportunity for Torus Actions. As it is seen in this article, the profits made by Belle through dermatology applications enable us to support and consolidate our research and development resources. Through this investment, we are able to develop even more in our research and development of our artificial intelligence.
Here is the press release from June 29th 2022:
Medzino is a US-based telehealth company, and one of our newest partners/customers. You can see our AI solutions on the website (https://medzino.com; scroll down to the “Skin” section)